We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Can NuScale's Commercial Potential Justify Its Valuation?
Read MoreHide Full Article
Key Takeaways
NuScale's approved reactor designs and supplier network provide a meaningful commercial head start.
NuScale's 2027 revenue outlook depends on projects advancing into revenue-producing phases.
NuScale trades at 28.6X forward sales, leaving little room for project delays or financing setbacks.
NuScale Power Corporation (SMR - Free Report) has a credible path toward commercializing its small modular reactor technology, supported by U.S. regulatory approval, supplier readiness and ample liquidity. The opportunity is substantial, but so are the expectations embedded in the stock.
The key question is whether that head start can convert into binding customer agreements and recurring revenues fast enough to justify a valuation that already discounts major future progress.
NuScale Has Built a Meaningful Commercial Head Start
NuScale’s 50-megawatt and 77-megawatt reactor designs have U.S. regulatory approval, while its technology uses commercially available low-enriched uranium. Detailed design work for critical-path components is substantially complete, and agreements are in place with more than half of its network of more than 60 suppliers.
The company ended the second quarter with about $1.9 billion in cash, cash equivalents and short- and long-term investments, giving it room to fund design finalization, fuel-system readiness and supply-chain work ahead of orders. GE Vernova (GEV - Free Report) , through GE Vernova Hitachi Nuclear Energy, is advancing the BWRX-300 small modular reactor, while Oklo Inc. (OKLO - Free Report) is building an advanced-nuclear platform spanning power, fuel and isotopes, reinforcing how execution is becoming the key differentiator across the sector.
SMR’s Revenue Outlook Requires a Major Step-Up
The Zacks Consensus Estimate projects 2026 revenues of about $33 million and 2027 revenues of about $183 million. That implies a sharp commercial step-up from a business that generated only $0.1 million in second-quarter 2026 revenues after RoPower front-end engineering work ended.
Image Source: Zacks Investment Research
Reaching that 2027 level depends on projects moving into revenue-producing phases. ENTRA1 and the Tennessee Valley Authority are still working toward definitive power purchase agreements, while RoPower requires financing before pre-engineering, procurement and construction work can resume.
NuScale’s Valuation Leaves Little Room for Slippage
SMR trades at 28.6X forward 12-month sales, far above the 4.5X multiple for the Zacks sub-industry. The premium reflects investor willingness to pay for regulatory progress and future commercialization rather than current revenues.
Image Source: Zacks Investment Research
That leaves less room for project delays, financing setbacks or slower-than-expected licensing activity. Until customer agreements convert into sustained engineering, equipment and service revenues, much of the investment case rests on execution that has yet to be demonstrated at scale.
SMR’s Cash Strength Comes at a Dilution Cost
NuScale sold 86.6 million Class A shares during the second quarter for $962.1 million in gross proceeds. Class A shares outstanding rose to about 410.4 million at June 30, 2026, from 318.5 million at year-end 2025.
The balance sheet now provides substantial flexibility, but the funding came at a meaningful ownership cost to existing shareholders. If commercial projects require more capital before recurring customer cash inflows develop, additional equity issuance could create further dilution.
NuScale’s Ranking Supports Patience Over Valuation Chasing
NuScale’s commercial position is stronger than its current revenue base suggests, but the valuation already assumes a sizable portion of that future opportunity. The setup favors watching contract conversion and project financing closely rather than treating regulatory readiness as sufficient proof of commercial success.
SMR currently carries a Zacks Rank #2 (Buy) and a Momentum Score of A, a constructive combination for near-term price action. Yet its Value Score of F, Growth Score of F and VGM Score of F show that the broader style profile remains weak. The ranking supports a favorable near-term view, while the Style Scores reinforce the need for discipline around valuation and execution.
View the Zacks #1 Rank List
Image: Bigstock
Can NuScale's Commercial Potential Justify Its Valuation?
Key Takeaways
NuScale Power Corporation (SMR - Free Report) has a credible path toward commercializing its small modular reactor technology, supported by U.S. regulatory approval, supplier readiness and ample liquidity. The opportunity is substantial, but so are the expectations embedded in the stock.
The key question is whether that head start can convert into binding customer agreements and recurring revenues fast enough to justify a valuation that already discounts major future progress.
NuScale Has Built a Meaningful Commercial Head Start
NuScale’s 50-megawatt and 77-megawatt reactor designs have U.S. regulatory approval, while its technology uses commercially available low-enriched uranium. Detailed design work for critical-path components is substantially complete, and agreements are in place with more than half of its network of more than 60 suppliers.
The company ended the second quarter with about $1.9 billion in cash, cash equivalents and short- and long-term investments, giving it room to fund design finalization, fuel-system readiness and supply-chain work ahead of orders. GE Vernova (GEV - Free Report) , through GE Vernova Hitachi Nuclear Energy, is advancing the BWRX-300 small modular reactor, while Oklo Inc. (OKLO - Free Report) is building an advanced-nuclear platform spanning power, fuel and isotopes, reinforcing how execution is becoming the key differentiator across the sector.
SMR’s Revenue Outlook Requires a Major Step-Up
The Zacks Consensus Estimate projects 2026 revenues of about $33 million and 2027 revenues of about $183 million. That implies a sharp commercial step-up from a business that generated only $0.1 million in second-quarter 2026 revenues after RoPower front-end engineering work ended.
Reaching that 2027 level depends on projects moving into revenue-producing phases. ENTRA1 and the Tennessee Valley Authority are still working toward definitive power purchase agreements, while RoPower requires financing before pre-engineering, procurement and construction work can resume.
NuScale’s Valuation Leaves Little Room for Slippage
SMR trades at 28.6X forward 12-month sales, far above the 4.5X multiple for the Zacks sub-industry. The premium reflects investor willingness to pay for regulatory progress and future commercialization rather than current revenues.
Image Source: Zacks Investment Research
That leaves less room for project delays, financing setbacks or slower-than-expected licensing activity. Until customer agreements convert into sustained engineering, equipment and service revenues, much of the investment case rests on execution that has yet to be demonstrated at scale.
SMR’s Cash Strength Comes at a Dilution Cost
NuScale sold 86.6 million Class A shares during the second quarter for $962.1 million in gross proceeds. Class A shares outstanding rose to about 410.4 million at June 30, 2026, from 318.5 million at year-end 2025.
The balance sheet now provides substantial flexibility, but the funding came at a meaningful ownership cost to existing shareholders. If commercial projects require more capital before recurring customer cash inflows develop, additional equity issuance could create further dilution.
NuScale’s Ranking Supports Patience Over Valuation Chasing
NuScale’s commercial position is stronger than its current revenue base suggests, but the valuation already assumes a sizable portion of that future opportunity. The setup favors watching contract conversion and project financing closely rather than treating regulatory readiness as sufficient proof of commercial success.
SMR currently carries a Zacks Rank #2 (Buy) and a Momentum Score of A, a constructive combination for near-term price action. Yet its Value Score of F, Growth Score of F and VGM Score of F show that the broader style profile remains weak. The ranking supports a favorable near-term view, while the Style Scores reinforce the need for discipline around valuation and execution.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.